Table 2 The definitions of metabolic syndrome were established according to the WHO, NCEP ATP III and IDF
From: Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
Criteria of metabolic syndrome | Organisation (year) (reference) | ||||
|---|---|---|---|---|---|
IDF (2005) [22] | Harmonised criteria provided, among others, by IDF and AHA (2009) [23] | ||||
Required | At least 1 of the following: | Not applicable | - Increased WC—values depending on ethnicity (for instance in Europeans ≥ 94 cm [men] or ≥ 80 cm [women]);—BMI > 30 kg/m2 is also acceptable | Not applicable | |
- Impaired fasting glucose - Impaired glucose tolerance - Diabetes - IR (assessed by the HEC) | |||||
Additional | AND at least 2 of the following: | Any 3 of the following: | AND any 2 of the following: | Any 3 of the following: | |
Central obesity | - WHR > 0.9 [men] or > 0.85 [women] and/or—BMI > 30 kg/m2 | - WC ≥ 102 cm (≥ 40 in) [men] or ≥ 88 cm (≥ 35 in) [women] | Included in the required criterion | - Increased WC—values depending on ethnicity (for instance in Europeans ≥ 94 cm [men] or ≥ 80 cm [women]) | |
HDL-C | - HDL-C < 0.9 mmol/L (< 35 mg/dL) [men] or < 1.0 mmol/L (< 39 mg/dL) [women] and/or—TG ≥ 1.7 mmol/L (≥ 150 mg/dL) | - < 1.03 mmol/L (< 40 mg/dL) [men] or < 1.29 mmol/L (< 50 mg/dL) [women] or—pharmacologic treatment for reduced HDL-C | - < 1.03 mmol/L (< 40 mg/dL) [men] or < 1.29 mmol/L (< 50 mg/dL) [women] or—pharmacologic treatment for reduced HDL-C | - < 1.03 mmol/L (< 40 mg/dL) [men] or < 1.29 mmol/L (< 50 mg/dL) [women] or—pharmacologic treatment for reduced HDL-C | |
TG | - ≥ 1.7 mmol/L (≥ 150 mg/dL) or—pharmacologic treatment for elevated TG | - ≥ 1.7 mmol/L (≥ 150 mg/dL) or—pharmacologic treatment for elevated TG | - ≥ 1.7 mmol/L (≥ 150 mg/dL) or—pharmacologic treatment for elevated TG | ||
Glycaemia | Included in the required criterion | - Fasting glycaemia ≥ 5.6 mmol/L (≥ 100 mg/dL) or—pharmacologic treatment for hyperglycaemia | - Fasting glycaemia ≥ 5.6 mmol/L (≥ 100 mg/dL) or—diagnosed T2D | - Fasting glycaemia ≥ 5.6 mmol/L (≥ 100 mg/dL) or—pharmacologic treatment for hyperglycaemia | |
Blood pressure | - BP ≥ 140/90 mmHg | - Systolic BP ≥ 130 mmHg or—diastolic BP ≥ 85 mmHg or—pharmacologic treatment for hypertension | - Systolic BP ≥ 130 mmHg or—diastolic BP ≥ 85 mmHg or—pharmacologic treatment for hypertension | - Systolic BP ≥ 130 mmHg and/or—diastolic BP ≥ 85 mmHg or pharmacologic treatment for hypertension | |
Other | - Urinary albumin excretion rate 20 µg/min or—ACR ≥ 30 mg/g | – | – | – | |